炭疽杆菌经鼻感染后早期致死因子与水肿因子入血扩散研究
该研究在小鼠经鼻感染炭疽杆菌模型中,用敏感定量方法检测致死因子(LF)和水肿因子(EF)的酶活性。攻击后1小时,仅7%小鼠出现菌血症,但100%小鼠血中检出LF、42%检出EF;保护抗原促进两者入血,毒素对细菌在血、脾、肝的系统播散有重要作用,提示毒素可作为炭疽早期诊断和治疗的靶点。
要点
- 经鼻感染后1小时,7%小鼠菌血症,但100%检出LF、42%检出EF。
- 保护抗原促进LF和EF向血液扩散。
- 毒素在炭疽杆菌早期系统播散中起重要作用,可作早期干预靶点。
核心结论
- 经鼻感染模型中,毒素迅速入血并在细菌早期系统播散中起重要且新颖的作用,可能成为炭疽早期诊断和治疗的靶点。
研究设计与样本
- 使用敏感定量方法检测小鼠经鼻攻击野生型炭疽杆菌株或保护抗原缺陷同源突变株后EF和LF的酶活性。
- 另用小鼠中毒模型验证LT和ET可不依赖细菌在循环中快速扩散。
主要发现
- 攻击后1小时,仅7%小鼠出现菌血症,但100%小鼠血中检出LF、42%小鼠血中检出EF。
- 保护抗原促进LF和EF扩散进入血液。
- 毒素对炭疽杆菌在血液、脾和肝脏的系统播散起重要作用。
- 小鼠中毒模型证实LT和ET可不依赖细菌在循环中快速扩散。
临床怎么用
- 在吸入性炭疽早期,即使菌血症率低,也应关注毒素入血,可将毒素作为早期诊断和治疗的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lethal and edema toxins are critical virulence factors of Bacillus anthracis. Few data are available on their presence in the early stage of intranasal infection. METHODS: To investigate the diffusion of edema factor (EF) and lethal factor (LF), we use sensitive quantitative methods to measure their enzymatic activities in mice intranasally challenged with a wild-type B anthracis strain or with an isogenic mutant deficient for the protective antigen. RESULTS: One hour after mouse challenge, although only 7% of mice presented bacteremia, LF and EF were detected in the blood of 100% and 42% of mice, respectively. Protective antigen facilitated the diffusion of LF and EF into the blood compartment. Toxins played a significant role in the systemic dissemination of B anthracis in the blood, spleen, and liver. A mouse model of intoxination further confirmed that LT and ET could diffuse rapidly in the circulation, independently of bacteria. CONCLUSIONS: In this inhalational model, toxins have disseminated rapidly in the blood, playing a significant and novel role in the early systemic diffusion of bacteria, demonstrating that they may represent a very early target for the diagnosis and the treatment of anthrax.
引用
- Rougeaux C, Becher F, Goossens PL, et al. Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection. J Infect Dis. 2020. PMID: 31574153. doi:10.1093/infdis/jiz497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。